Research grants are a great source of non-dilutive capital that can enable you to further de-risk the science and technology that serve as the foundation of your business. Additionally, they can be an effective way to externally validate your ideas and research plan. The challenge is that the grant review process can be lengthy and there are limitations on what the funds can be used for. Tips on obtaining small business grants are included here.
2015 SBIR Omnibus Solicitation
The 2015 Omnibus Solicitations of the NIH and CDC are now available for Small Business Innovation Resesearch (SBIR) program.
Please see the NIH SBIR website (http://sbir.nih.gov) for details and solicitation. Additional information can be found in the NIH/CDC SBIR Contract Solicitation PHS 2015-1 at http://grants.nih.gov/grants/funding/SBIRContract/PHS2015-1.pdf.
The deadline for contract proposal submissions is Wednesday, November 5, 2014, at 4:30 pm ET and submissions must be on paper.
Notification of Phase 1 Grant Solicitations
National Science Foundation (NSF) SBIR & STTR Grants
SBIR Phase I Solicitation (NSF 14-603): Deadline is December 2, 2014
STTR Phase I Solicitaion (NSF 14-540): Deadline is December 4, 2014
Computer & Information Science & Engineering
Education and Human Resources
Environmental Research & Education
International & Integrative Activities
Mathematical & Physical Sciences
Social, Behavioral & Economic Sciences
For more information on Q&A Webinars: SBIR/STTR Phase I Q&A Webinars
2014 SBIR/STTR Omnibus announcement
The 2014 Omnibus Grant Solicitations of the NIH, CDC, FDA and ACF are now available for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Please note that applicants may now switch between the SBIR and STTR programs for the Omnibus solicitation and all NIH SBIR/STTR funding opportunity announcements (FOAs). A FOA for a Direct SBIR Phase II will be coming soon-- stay tuned to the NIH SBIR homepage for details.
Please find the 2014 SBIR/STTR Omnibus solicitations and accompanying resources below:
Standard Application Due Date: December 5, 2014.
AIDS and AIDS-related Application Due Date: January 7, 2015.
Small business concerns (SBCs) may also check the Special Announcements Table on the NIH SBIR website
for targeted NIH SBIR/STTR FOAs issued by individual Institutes and Centers (ICs).
HHS Grant Announcements
CDC: Strengthening HIV Strategic Information Activities in the Republic of Senegal under the President's Emergency Plan for AIDS Relief (PEPFAR) Modification 1 (CDC-RFA-GH15-1573)
NIH: Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01) Grant (RFA-DK-14-023)
CDC: Increasing Capacity of the Dominican Republic Ministry of Health in the Areas of Blood Safety, Monitoring and Evaluation, Epidemiology, and Health Information Systems under the President's Emergency Plan for AIDS Relief (PEPFAR) Modification 1 (CDC-RFA-GH15-1518)
NIH: Brain Somatic Mosaicism and its Role in Psychiatric Disorders (Collaborative U01) Grant (PAR-15-022)
LSDF 2014-2015 Granting Programs Now Open
LSDF is now accepting pre-proposals from Washington for-profit and non-profit organizations for two granting programs. The second pre-proposal submission deadline for both programs is January 7, 2015:
Matching Grants – program and project – require strategic co-investment by external funders. Applicants must speak with LSDF staff to determine if a pre-proposal may be submitted:
- Program grants support large-scale life sciences commercialization-related initiatives. The maximum award is $1 million in total costs; a 1:3 cash match of LSDF funds is required.
- Project grants support studies to advance promising health-related technologies along the commercialization pathway. The maximum award is $500,000 in total costs; a 1:1 cash match of LSDF funds is required.
Proof of Concept Grants provide up to $250,000 in total costs to enhance the commercial viability of health-related technologies or concepts developed by non-profit organizations or enhance the competitiveness of early-stage life sciences companies for private equity investment.
The Request for Proposals, application documents and grant competitions calendar are available here.
NIH's SBIR/STTR Niche Assessment Program
The NIH’s SBIR/STTR Niche Assessment Program (NAP) is a nationwide program to help jump-start an SBIR/STTR Phase I awardee's commercialization efforts. Technology Niche Analyses® are provided by Foresight for 138 NIH SBIR/STTR Phase I awardees. These analyses are often awarded on a first come, first served basis and assess potential applications for a technology and then for one viable application, it provides an assessment of the:
1. needs and concerns of end-users;
2. competing technologies and competing products;
3. competitive advantage of the SBIR/STTR-developed technology;
4. market size and potential market
5. barriers to market entry (pricing, competition, government regulations, manufacturing challenges, capital, etc.);
6. market drivers;
7. status of market and industry trends;
8. potential customers, licensees, investors, or other commercialization partners; and,
9. the price customers are likely to pay.
Each participant receives an in-depth report. Oftentimes the small business can use this information in their commercialization plans for their Phase II applications. For more information, see Notice NOT-OD-13-109 that was placed in the NIH Guide for Grants and Contracts on August 28, 2013.